Clinical Observation of Shenmai Injection in Treatment of Primary Sjogren Syndrome / 中国药房
China Pharmacy
;
(12)2001.
Article
in Chinese
| WPRIM
| ID: wpr-533603
ABSTRACT
OBJECTIVE:
To observe the clinical effect of Shenmai injection for primary sjogren syndrome.METHODS:
61 patients were randomized to receive anethole trithione (control group,n=29) or anethole trithione and Shenmai injection (treatment group,n=32) respectively with 15 days as a course of treatment.RESULTS:
The total effective rate was 68.96% for control group and 90.63% for treatment group.There were 3 cases of abdominal discomfort ordiarrhea in control group,and no serious ADR was detected in treatment group.Significant difference was noted between two groups (P
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
China Pharmacy
Year:
2001
Type:
Article
Similar
MEDLINE
...
LILACS
LIS